EDF Ventures
About Us The Team Portfolio News & Events Limited Partners Contact
Nowadays,the replica bags uk is not only limited to the replica gucci and sale of high-end leather goods and rolex replica ,but has become a replica handbags trend indicator in the fields of hermes replica ,accessories,shoes,bags,jewelry,watches,media,and famous wines.

EDF Ventures is a leading venture capital firm investing in early-stage healthcare companies. Our partners bring deep domain knowledge, extensive networks and a distinguished track record to every endeavor.


Featured Portfolio Company


Lycera Announces Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with Ulcerative Colitis

Lycera Congratulates Dr. Peter L. Toogood for His Receipt of the 2016 Heroes of Chemistry Award from the American Chemical Society (ACS)

Lycera Announces Progress in Immuno-Oncology Program Presented at the 2016 American Association for Cancer Research (AACR) Annual Meeting

Lycera Announces Presentations of Positive Preclinical Results for Lead Candidate LYC-30937 and for Selective Rho kinase Inhibitor Program at the 11th Congress of the European Crohn's and Colitis Organization (ECCO)

IntelePeer Provides Near-Real Time Provisioning for Cisco Spark Call via its new API

Lycera Announces Celgene Has Exercised its Option to License Portfolio of Ex Vivo RORgamma Agonist Compounds under Global Strategic Collaboration

Lycera Corp Expands Leadership Team, Appoints Alex G. Howarth as Chief Financial Officer

Lycera and Celgene Announce an Exclusive Strategic Collaboration to Advance Novel Immune Modulators

Direct Flow Medical Names Daniel Lemaitre as Chief Executive Officer

Lycera Initiates Phase 1 Clinical Trial of LYC-30937, a First-In-Class ATPase Modulator for Inflammatory Bowel Disease

Lycera Announces Milestone in Merck Collaboration

Cerenis Therapeutics launches its IPO on the Euronext regulated market in Paris

Lycera Expands Leadership Team, Names H. Jeffrey Wilkins, M.D., as Chief Medical Officer








Please do not submit any information or other materials that you consider to be confidential or proprietary. Because of the large number of business plans and related materials that EDF Ventures reviews, and the similarity of many such plans and materials, EDF Ventures cannot accept responsibility for protecting against misuse or disclosure of any confidential or proprietary information or other materials in the absence of EDF Ventures' express written agreement to do so.

Terms  |  Privacy



Robert Noakes